Pharmaceutical Products Supply
Originaltitel der Bekanntmachung
Bulgaria – Pharmaceutical products – „Доставка на лекарствени продукти за нуждите на МБАЛ “Д-р Братан Шукеров”АД“
Opportunity Score
Warum diese Bewertung?
Chance
70 / 100
Komplexität
60 / 100
Risikofaktoren
Stringent licensing requirements may exclude non-Bulgarian entities without proper authorization.
Structured data indicates EU funding, but XML notice states no EU funds. This inconsistency could affect contract fundi...
Restricted procedure — pre-qualification required
Tiefe Portfolioanalyse
Verwendet:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Überblick
Moderate opportunityWichtige Fakten
- BGN 8.4M estimated value
- Dynamic Purchasing System (DPS)
- Supplies contract
- 1 lot
- Supply of pharmaceutical products as defined in the technical specification.
- Estimated quantities are provided but not guaranteed.
Vollständige Zusammenfassung anzeigen
This tender is a Dynamic Purchasing System (DPS) for the supply of pharmaceutical products to MBAL Dr. Bratan Shukerov AD in Smolyan, Bulgaria. The estimated total value is 8,416,335 BGN for a 24-month period. The procedure is restricted, with award based on lowest price. The deadline for initial applications is 24 June 2027, far in the future, suggesting a long-term DPS. Key eligibility requires valid manufacturing or wholesale authorization for medicinal products in Bulgaria or EU equivalent. Note: There is an inconsistency regarding EU funding—structured data indicates EU-funded, but the XML notice states no EU funds.
Risiken
Stringent licensing requirements may exclude non-Bulgarian entities without proper authorization.
Structured data indicates EU funding, but XML notice states no EU funds. This inconsistency could affect contract fundi...
Restricted procedure — pre-qualification required
Analyse kann unvollständig sein
Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.
Wichtige Anforderungen
Technical
- Must hold valid manufacturing or wholesale authorization for medicinal products in Bulgaria or EU equivalent.
- Compliance with Bulgarian Medicines Act (ZLPHM).
- Candidates must apply for inclusion in the DPS; initial application required.
Anforderungen können unvollständig sein.
Zuschlagskriterien
Lot 1
Auftraggeber
Ort
гр. Смолян, BGR
Website
Auftraggeberprofil
Kennung
120503871
Tätigkeit
Health
Lose (1)
LOT-0001
Pharmaceutical Products Supply
Supply of medicinal products as per the technical specification (not analyzed). Quantities are estimated and not guaranteed. The DPS runs for 24 months from September 2024.
BGN 8.4M
Geschätzter Wert
Ort
Dauer
Kategorie
Zuschlagskriterien
Zuschlagsdetails
Обществената поръчка ще се възложи въз основа на икономически най-изгодната оферта при критерий за възлагане „най-ниска цена”
Hinweis zum Wert
Originale TED-Daten anzeigen
Originaler Los-Titel
„Доставка на лекарствени продукти за нуждите на МБАЛ “Д-р Братан Шукеров”АД“
Originale TED-Beschreibung
„Доставка на лекарствени продукти за нуждите на МБАЛ “Д-р Братан Шукеров”АД“. Лекарствените продукти са посочени по номенклатурни единици и са подробно представени по лекарствени форми, количество лекарствено вещество, единица мярка и необходимо прогнозно количество в приложената към документацията първоначална „Техническа спецификация“. Посочените количества в приложената към документацията „Техническа спецификация“ са прогнозни и не задължават Възложителя да ги закупи в пълен обем, а съобразно своята необходимост.
Vergabedetails
- Veröffentlichungsdatum
- 26 Jun 2024
- Sprachen
- Bulgarian
Referenzmetadaten
- Rechtsgrundlage
- 32014L0024
Referenz-IDs
- Ausschreibungs-ID
- 377194-2024
Dokumente (1)
Ähnliche Ausschreibungen
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)
Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Belgium – Pharmaceutical products – Antimycotica
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)
Denmark – Pharmaceutical products – Amgros 2027 1.1170.a
Opportunity Score
Warum diese Bewertung?
Chance
70 / 100
Komplexität
60 / 100
Risikofaktoren
Stringent licensing requirements may exclude non-Bulgarian entities without proper authorization.
Structured data indicates EU funding, but XML notice states no EU funds. This inconsistency could affect contract fundi...
Restricted procedure — pre-qualification required
Tiefe Portfolioanalyse
Verwendet:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications